World first trial set to revolutionise treatment of neurological conditions
28 Feb 2017
St Vincent’s neurologists will seek to extend a world-first clinical trial in which they have delivered epilepsy drugs direct to the brain of a patient, to apply the procedure to conditions such as Parkinson’s, Alzheimer’s and stroke.
The trial, conducted late last year on a epilepsy patient, Natalie Kallelea from Numerkah in regional Victoria, who had been experiencing up to 8 seizures a day and had become a prisoner in her own home, has reduced drug side effects but better still, she is now seizure free.
The research being conducted by St Vincent’s Director of Neurology, Professor Mark Cook, involved implanting a pump that sends medication directly from the patient’s stomach via a tiny tube, directly to the brain.
“Epilepsy is an awful condition,” Professor Cook said.
“There’s nothing more satisfying than being able to fix that. There’s nothing more dramatic you ever get to do in clinical medicine; it’s just spectacular. But it’s important to realise these breakthroughs some through research.”
The research is set to benefit from St Vincent’s latest appeal, launched at Opera in the Market. You can help St Vincent’s extend this trial and help more patients like Natalie by donating online or texting ‘NEURO’ to 0400 807 807 and follow the link to complete your donation on your mobile.
World-first 'Fitbit for the brain'
Aboriginal Health at St Vincent’s
Experts urgent message to GPs over Hep C treatment
Researchers hoping to begin BoPen clinical trials in three years
Meet our volunteer Peter Dwyer
09 May 2016
This National Volunteer Week, we say thank you to one of our many volunteers Peter Dwyer, who visits our aged care residents once a week to play guitar and sing for them as a musical volunteer.